Developing Interim Outcome Measures for Multi-Arm Multistage Clinical Trials in Multiple Sclerosis
Background and Objectives Multi-arm multistage (MAMS) clinical trials use interim outcome stage analyses to test multiple candidate treatments, determining which should proceed to the next trial stage. The reduced time, cost, and participant numbers, compared with current separated phases 2 and 3 clinical trials, could...